coronavirus vaccine it is developing should be ready by early 2021 for distribution worldwide, including the United States.Yin Weidong, the CEO of SinoVac, vowed to apply to the U.S.
Food and Drug Administration to sell CoronaVac in the United States if it passes its third and final round of testing in humans.
Yin said he personally has been given the experimental vaccine. Coronavirus: Canada adds 1,329 cases, 5 deaths Thursday “At the very beginning, our strategy was designed for China and for Wuhan.